BRIEF-BioNTech Says Pfizer,Co Request Regulatory Agencies Expand Emergency Use Of Their Covid-19 Vaccine To Adolescents
BRIEF-BioNTech Says Pfizer,Co Request Regulatory Agencies Expand Emergency Use Of Their Covid-19 Vaccine To Adolescents
* PFIZER AND BIONTECH REQUEST REGULATORY AGENCIES EXPAND EMERGENCY USE OF THEIR COVID-19 VACCINE TO ADOLESCENTS
* REQUESTED AMENDMENTS TO U.S. EUA OF THE PFIZER-BIONTECH VACCINE TO EXPAND USE IN ADOLESCENTS 12 TO 15 YEARS OF AGE
* REQUESTS BASED ON DATA FROM PIVOTAL PHASE 3 TRIAL IN ADOLESCENTS 12 TO 15 YEARS OF AGE WITH OR WITHOUT PRIOR EVIDENCE OF SARS-COV-2 INFECTION
* COMPANIES PLAN TO REQUEST SIMILAR RULINGS BY OTHER REGULATORY AUTHORITIES WORLDWIDE IN COMING DAYS
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
April 9 (Reuters) - BioNTech SE :
* PFIZER AND BIONTECH REQUEST REGULATORY AGENCIES EXPAND EMERGENCY USE OF THEIR COVID-19 VACCINE TO ADOLESCENTS
* REQUESTED AMENDMENTS TO U.S. EUA OF THE PFIZER-BIONTECH VACCINE TO EXPAND USE IN ADOLESCENTS 12 TO 15 YEARS OF AGE
* REQUESTS BASED ON DATA FROM PIVOTAL PHASE 3 TRIAL IN ADOLESCENTS 12 TO 15 YEARS OF AGE WITH OR WITHOUT PRIOR EVIDENCE OF SARS-COV-2 INFECTION
* COMPANIES PLAN TO REQUEST SIMILAR RULINGS BY OTHER REGULATORY AUTHORITIES WORLDWIDE IN COMING DAYS
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
路透4月9日电-BioNTech SE：*辉瑞和BioNtech要求监管机构将其新冠肺炎疫苗的紧急使用范围扩大至青少年*要求修改辉瑞-BioNTech疫苗的美国EUA，以扩大在12至15岁青少年中的使用*基于有或没有SARS-COV-2感染先前证据的12至15岁青少年关键阶段3期试验的数据提出的请求*公司计划在未来几天要求全球其他监管机构做出类似裁决Eikon的源文本：进一步的公司报道：(Reurs.Briefs@thomsonreurs.com；)
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧